Skip to main content

Partnering with Industry

Screen Clinical services are written to compliment patient-centred care and we ensure they are flexible in terms of implementation and cost.

We can apply for full sponsorship for services, in which case clinical reviews may be delivered with no cost implications to your GP Practice or Healthcare Organisation. See our expression of interest forms or contact us directly.

We are continually researching and developing new services which will be relevant for GP practices and strategic bodies. Please contact Screen Clinical for further information on info@screenclinical.com.

See what services we offer & express your interest below

Type 2 Diabetes

  • Improve outcomes for T2DM patients, practices and the Health service
  • Validation of the practice diabetes register for QoF or CDM
  • Align management of T2DM management to NICE [NG28] and ADA/EASD guidelines
  • Provide access to an audit tool to stratify patients to help healthcare organisations understand the burden of illness, identify gaps in care processes and opportunities for quality improvement in patient care
  • Provisions of face-to-face, virtual or telephone clinics where required
  • Available to practices or strategic healthcare organisations

COPD

  • The aim of the service is to support General Practice to provide a COPD service for patients who are not under specialist care.
  • The service will offer identified COPD patients the opportunity to receive a therapy review within a GP practice either virtually or face to face.
  • We can stratify the Practice’s COPD patient population to fully understand the burden of illness, identify gaps in patient care and therefore opportunities for clinical improvement.
  • We can support patients not achieving COPD treatment goals in alignment with national/local guidelines or policies, through the provision of pharmacist clinical capacity.
  • Our overarching aim is to improve health outcomes for patients with COPD

Self Monitoring of Blood Glucose

  • Improve outcomes in SMBG for patients, practices and the NHS
  • Increase the value associated with SMBG testing by:
    • stopping testing in those patients where it is not indicated
    • reducing over ordering or over testing in patients with testing or ordering patterns not in line with local and national guidelines
    • align prescribing to local and national guidelines.
  • Provide a comprehensive patient educational support where necessary on:
    • Appropriate testing frequency for patients over or under testing
    • Latest guidance on BG monitoring requirements for drivers (Driving guidance)
  • Validation of diabetes register and identification of gaps in care processes
  • Available to practices or strategic healthcare organisations

Osteoporosis and Vitamin D

  • Reduce fracture risk in the practice by highlighting gaps in treatment and validation of practice osteoporosis register
  • Ensure general prescribing of vitamin D is in line with local and NICE guidance
  • Review / risk assess patients on the osteoporosis register for adjunct therapy of vitamin D
  • Minimise sub optimal therapy due to intolerance to calcium products
  • Review prescribing to care home patients/elderly to optimise therapy based on formulation, ease of use and acceptability
  • Review prescribing of specials and food supplements
  • Available to practices or strategic healthcare organisations

Pen Needles

  • Care optimisation for patients prescribed insulin to enhance outcomes and patient safety:
    • Rationalisation of pen needle prescribing to those recommended by local guidelines
    • Identification of patients under-or over-ordering insulin needles
    • Provide patient and practice education on optimising safety and outcomes for patients using insulin
  • Reduce burden associated with inappropriate needle usage and injection technique
  • Validation of diabetes register and identification of gaps in care processes
  • Available to practices or strategic healthcare organisations

Atrial Fibrillation and Anticoagulation

  • Review of therapeutic management of oral anticoagulation (OAC) prescribing ensuring risk reduction and improve outcomes for patients, practices and the NHS
  • Clinical assessment and monitoring of patients currently receiving OAC and those who would benefit from OAC
  • AF register validation and CHA2DS2-VASc scoring
  • Implement best practice based on NICE Clinical guidelines CG180 and QS93
  • Deliver AF QOF indicators and local and national prescribing guidelines and prescribing directives
  • Service includes face-to-face, virtual or telephone clinics with a Screen Clinical pharmacist to provide annual OAC review
  • Implement best practice based on the ESC clinical guidelines and NICE CG180 and QS93